Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 107 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

  Article Access Statistics

Year : 2019 | Volume:  9 | Issue Number:  3 | Page:  127-128

EDITORIAL

Onasemnogene abeparvovec for spinal muscular atrophy: The costlier drug ever
Mahajan Rajiv

Number of times this article was viewed 312
Number of times this article has been printed  from the site 37
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal